Mutations in TP53 are associated with a poor prognosis in many cancers and germline mutations in this gene cause the Li-Fraumeni syndrome which increases the susceptibility to diverse cancer types (Malkin et al., 1979; Srivastava et al., 1990; Kandoth et al., 2013; Donehower et al., 2019; Mantovani et al., 2019). Here, TP53 is linked to cancer.